Lyophilisate and solvent for suspension for injection.
Attenuated Live Canine Distemper Virus, Rockborn strain.
Attenuated Live Canine Adenovirus type 2 (CAV-2) Manhattan strain.
Inactivated Leptospira interrogans, canicola serovariety.
Inactivated Leptospira interrogans, icterohemorragiae serovariety.
TARGET SPECIES AND INDICATIONS
Dogs (puppies and adults).
Active immunization of dogs (puppies and adults) to prevent the mortality and the disease caused by Canine Distemper Virus, to prevent the mortality and to reduce the clinical signs due to the Infectious Canine Hepatitis and Leptospira, and to reduce the clinical signs and the infection caused by CanineAdenovirus type 2.
POSOLOGY AND METHOD OF ADMINISTRATION
Route: Subcutaneous in neck or back region.
Dose: 1 ml
Reconstitute the lyophilized fraction with the solvent that contains the Leptospiras, homogenize by adequate agitation, to obtain a homogeneous suspension
First vaccination: administer the first dose to 6-8 weeks of life and the second dose to 3 a 5 weeks later. Administer a third dose from 12 weeks of life if the second dose is applied before 12 weeks of life.
PRESENTATION AND WITHDRAWAL TIME
10 vials with 1 dose.